Navigation Links
Medco Shareholders Approve Merger With Express Scripts
Date:12/21/2011

FRANKLIN LAKES, N.J., Dec. 21, 2011 /PRNewswire/ -- Shareholders of Medco Health Solutions, Inc. (NYSE: MHS) today approved a proposed merger with Express Scripts.

(Logo: http://photos.prnewswire.com/prnh/20100609/MEDCOLOGO)

With approximately 72 percent of the shares entitled to vote present in person or by proxy at a special meeting held today, shareholders adopted the Agreement and Plan of Merger dated July 20, 2011 by a margin of 99 percent to one percent, based on a preliminary tabulation.

In a non-binding advisory vote, shareholders also approved certain merger-related compensation arrangements for Medco's executive officers by a margin of 95 percent to five percent, based on a preliminary tabulation.

The merger is pending a parallel meeting of Express Scripts shareholders, required governmental consents, and other customary closing conditions.  Medco expects the merger transaction to close in the first half of 2012.

About Medco

Medco Health Solutions, Inc. (NYSE: MHS) is pioneering the world's most advanced pharmacy® and its clinical research and innovations are part of Medco making medicine smarter™ for more than 65 million members.

With more than 20,000 employees dedicated to improving patient health and reducing costs for a wide range of public and private sector clients, and 2010 revenues of $66 billion, Medco ranks 34th on the 2011 Fortune 500 list and is named among the world's most innovative, most admired and most trustworthy companies. 

For more information, go to http://www.medcohealth.com

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the risks and uncertainties that affect our business, particularly those mentioned in the Risk Factors section of the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission.       

 


'/>"/>
SOURCE Medco Health Solutions, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Combining Express Scripts and Medco Health Solutions Will Help Protect Americans From the Rising Costs of Prescription Medicine
2. Express Scripts and Medco Save Americans Tens of Billions in Healthcare Costs, New Economic Report Shows
3. National Coalition Continues Fight to Stop the Express Scripts/Medco Merger in Nations Capitol
4. Medco Research Institute Study Shows Some Patients Discontinue New Anticoagulant Drug Early, Which May Increase Stroke Risk
5. Nationwide Coalition Joins Reps. Courtney & Marino Outside U.S. Capitol To Oppose Express Scripts/Medco Merger
6. Lawmakers, Pharmacists Rally Against Express Scripts-Medco Merger Proposal at U.S. Capitol
7. Nationwide Coalition Issues Call To Action To Stop Express Scripts/Medco Merger
8. Nationwide Coalition Opposes Express Scripts/Medco Merger
9. Medco, Quest Diagnostics Personalized Medicine Study Yields Additional Clues about Patient Engagement
10. Medco Wins 2011 URAC Award for Best Practices in Health Care Consumer Empowerment and Protection
11. Merger of Express Scripts and Medco Health Solutions Will Address the Bipartisan Mandate for Safer, More Affordable, Higher Quality Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... April 19, 2017 Global Surgical Drainage Device ... tubes used to remove excess liquid and air. The ... urine, bile or lymph. Surgical drains are used in ... as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. ... to prevent accumulation of fluid e.g. blood or pus. ...
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group ... it is developing at Conejo Spectrum Business Park ... to Atara Biotherapeutics, Inc. , a biopharmaceutical ... and life-threatening diseases that have been underserved by ... T-cell therapies for cancer, autoimmune and infectious disease. ...
Breaking Medicine Technology:
(Date:4/25/2017)... Richmond, BC (PRWEB) , ... April 25, 2017 , ... ... patients from Richmond, BC, who live with dental fear and require sedation to receive ... anxiety at ease during various procedures, from hygienic cleanings to oral surgery, at ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... they rely on contracted partners to help with process innovation in drug formulation ... drug formulation experience along with state-of-the-art analytical equipment in support of their development ...
(Date:4/25/2017)... MN (PRWEB) , ... April 25, 2017 , ... Buyers ... and recreational users to dispensaries and head shops –can’t help but be heartened by ... for the tell-tale cannabis odor aptly described as “skunk smell.” At last they ...
(Date:4/25/2017)... ... 25, 2017 , ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley ... in Writing, set to publish in summer 2017. , Dr. Bobrow, MD, FACEP, ... Arizona College of Medicine. He also serves as Medical Director for the Bureau of ...
(Date:4/25/2017)... ... April 25, 2017 , ... Amendia, Inc., designer, developer, and ... partnership with and platinum sponsorship of Global Spine Outreach (“GSO”), a charitable organization ... of complex spine deformity cases, particularly in children. , GSO’s focus is to ...
Breaking Medicine News(10 mins):